LYSOPHOSPHATIDIC ACID TYPE 2 RECEPTOR AGONISTS IN TARGETED DRUG DEVELOPMENT OFFER BROAD THERAPEUTIC POTENTIAL

Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential

The growth factor-like lipid mediator, lysophosphatidic acid (LPA), is a potent signaling molecule that influences numerous physiologic and pathologic processes.Manipulation of LPA signaling is of growing pharmacotherapeutic interest, especially because LPA resembles compounds with drug-like features.The action of LPA is mediated through activation

read more



Constraining electroweakinos in the minimal Dirac gaugino model

Supersymmetric models with Dirac instead of Majorana gaugino masses have distinct phenomenological Waste Toner Unit consequences.In this paper, we investigate the electroweakino sector of the Minimal Dirac Gaugino Supersymmetric Standard Model (MDGSSM) with regards to dark matter (DM) and collider constraints.We delineate the parameter space where

read more